Publication | Open Access

Why phase II trials in cervical chemoprevention are negative: what have we learned?

Cervical Cancer ManagementCervical Cancer ScreeningCervical CancerCervical HealthHealth SciencesCancer ManagementClinical EndpointClinical TrialsGynecologyCervical ChemopreventionMetronomic ChemotherapyCancer TreatmentPublic HealthMedicineRadiation OncologyPhase Ii TrialsCancer ResearchCervical Cancer Prevention